An observational study in Cesarean Section and Dysmenorrhea, sponsored by Cairo University. Completed at 1 site in Egypt. Open to female participants aged 20 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-09-16.
Sponsored by Cairo University · Observational
The aim of this observational cross-sectional study is to investigate the association between cesarean scar mobility and menstrual pain severity in women following cesarean section. The study will enroll women aged 20 to 35 years with a history of cesarean delivery who experience menstrual pain. Baseline assessments will be performed to evaluate cesarean scar mobility, menstrual pain severity, pressure pain threshold, and related clinical characteristics. The findings will help clarify whether reduced cesarean scar mobility is associated with greater menstrual pain severity and may provide evidence supporting the clinical assessment of cesarean scars in women with post-cesarean menstrual pain.
Cesarean section is one of the most frequently performed surgical procedures worldwide. Although generally safe, postoperative scar formation and fascial adhesions may result in long-term alterations in tissue mobility and biomechanics. These changes have been suggested to contribute to persistent symptoms, including menstrual pain, chronic pelvic pain, abdominal tenderness, and functional impairment. Despite increasing interest in cesarean scar assessment, the relationship between scar mobility and menstrual pain severity has not been sufficiently investigated.
Restricted scar mobility may influence the mechanical behavior of the abdominal wall and surrounding fascial structures, potentially contributing to altered force transmission, increased tissue sensitivity, and pain during menstruation. Understanding this relationship may improve the clinical evaluation of women presenting with post-cesarean menstrual pain and assist in identifying patients who may benefit from targeted rehabilitation interventions.
This observational cross-sectional study aims to investigate the association between cesarean scar mobility and menstrual pain severity in women following cesarean section. Baseline measurements will be obtained to assess cesarean scar mobility, menstrual pain severity, pressure pain threshold, and selected demographic and obstetric characteristics. Correlation and regression analyses will be performed to determine whether cesarean scar mobility is associated with menstrual pain severity and whether it independently predicts menstrual pain after controlling for potential confounding variables.
The findings of this study are expected to improve understanding of the clinical significance of cesarean scar mobility in women with menstrual pain and provide evidence to support comprehensive scar assessment as part of women's health physical therapy practice.
398 studies on the registry are indexed under Dysmenorrhea; 96 are open to participants now.
This study's enrollment of 51 is below the median of 123 across 56 observational studies indexed under Dysmenorrhea.
Browse Dysmenorrhea studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Women aged 20-35 years with a previous cesarean section who experience menstrual pain.
Exclusion Criteria:
Menstrual Pain Severity
Menstrual pain severity will be assessed using the 10-cm Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater menstrual pain severity.
Time frame: Baseline
Cesarean Scar Mobility
Cesarean scar mobility will be assessed using the Adheremeter. Higher scores indicate
Time frame: Baseline
Pressure Pain Threshold
Pressure pain threshold will be measured using a pressure algometer. Higher values indicate a higher pressure pain threshold.
Time frame: Baseline
WaLIDD Score
The severity of dysmenorrhea will also be evaluated using the Working ability, Location, Intensity, Days of pain, and Dysmenorrhea (WaLIDD) Score as a secondary clinical measure. The total score ranges from 0 to 12, with higher scores indicating more severe dysmenorrhea.
Time frame: Baseline
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University